Alltracel Pharmaceuticals


Dublin-based Alltracel Pharmaceuticals is involved in developing and supplying wound care, oral care (including dental floss, toothbrushes and breath fresheners), skin care and cardiovascular health treatments. Some of the wound care products are sold under the 'm.doc' name. It joined Aim in July 2001 at 89p a share. A Czech joint venture called Nanopeutics is developing Nanospider technology, which will enable nanofiber materials to be produced that could transform a number of healthcare sectors (according to the company).

Sector: Health

News blog

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at Subscribe to AIM Micro RSS Feeds